Agripower France (ALAGP) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
7 Apr, 2026Executive summary
Order backlog surged to €16.6M as of December 31, 2025, up 82% from June 2025, driven by biomethane injection projects.
Strategic shift confirmed toward a developer-investor model in biomethane injection, with 90% of backlog now in this segment.
First-half results remain modest, with significant growth expected from the second half of 2025-2026.
Four new contracts totaling €9.8M signed in France, including three equity participations.
Financial highlights
Net revenue for H1 2025-2026 was €2.5M, up from €2.3M year-over-year.
EBITDA for H1 2025-2026 was -€1.2M, compared to -€1.0M in H1 2024-2025.
Operating loss widened to -€1.4M from -€1.1M year-over-year.
Net loss for the period was -€1.3M.
Cash available at December 31, 2025, was €3.3M, with net cash of €1.4M.
Outlook and guidance
Annual revenue target for 2025-2026 adjusted to around €8M due to project delays; over €16M targeted for 2026-2027.
Second half of 2025-2026 expected to see accelerated growth and near break-even operating results.
Commercial pipeline exceeds €20M across seven advanced projects.
Latest events from Agripower France
- Strategic pivot to biomethane injection, strong cash, and robust project pipeline drive growth.ALAGP
Trading Update28 Oct 2025 - Transition year with €4.8M revenue, €4.9M net loss, and strategic shift to biomethane injection.ALAGP
H2 202428 Oct 2025 - Revenue up 20%, losses halved, and biomethane projects fuel a strong €7M order backlog.ALAGP
H1 202528 Oct 2025 - Losses narrowed and order book grew as focus shifted to biomethane injection projects.ALAGP
H2 202528 Oct 2025